According to a paper, published in the American Journal of Endocrinology and Metabolism, it would seem that the blue pill has quite a lot of applications, most of them being very surprising. Blue pill reduces risk of type 2 diabetes and the clinical trials seem to confirm this finding.
Type 2 diabetes, also known as diabetes mellitus type 2 or noninsulin-dependent diabetes has its unique characteristics. First of all, type 2 diabetes has been found to affect only adult population. Moreover, the disease itself is known to produce a high level of blood sugar, followed by accumulated insulin resistance. It should be noted that in the case of type 2 diabetes, as opposed to type 1 diabetes, the liver produces insulin, but not enough.
Almost 90% percent of patients diagnosed with diabetes have type 2 diabetes, and most of them have issues concerning weight. In very rare instances, type 2 can lead to serious complications such as heart diseases, brain strokes and something called diabetic retinopathy.
When to go and see a doctor? Typically type 2 diabetes manifest itself through the “holy trinity” of symptoms. The triumvirate consists of polyuria, polydipsia and polyphagia. Other symptoms might include significant weight loss and eye problems.
As for the new study, it shows some promising results in the area of type 2 diabetes management and prevention. We stated before that people who are overweight have an increased risk of developing type 2 diabetes.
Now, in order to see if the blue pills actually gets the job done, the researchers selected a test group of 42 men and women. Most of them were good candidates for type 2 diabetes, as everyone exhibited symptoms linked to prediabetes and they all had a high BMI.
The experiment involved a small dose of Viagra (about 25 milligrams), administered three times a day, over a period of three months. But there is a catch to this: in order to see if Viagra actually boosts insulin sensitivity, half of the group received real blue pills, while the other half received placebos.
The result spoke for themselves: the group that received placebos did now show any improvement in terms of insulin sensitivity, while the others who received the sky-blue pill, showed major improvements.
Doctor Nancy Brown, the lead author of the study said that these result could actually prove to physicians that there are always other therapies that you can follow in order to help your patient.
Image source: www.compraviagraitalia.net